The rising interest in GLP-1 agonists for metabolic health has generated a debate about delivery routes : patches versus pills . Typically, GLP-1 drugs were solely available in oral form, but the emergence of patches offers a alternative way. Transdermal systems might benefit individuals experiencing difficulty taking oral medications, those seekin